[Recent neurobiological and related pharmaco-therapeutic acquisitions in Huntington's chorea].
D000661:Amphetamine / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001921:Brain / Q000378:metabolism / Q000473:pathology; D002090:Butyrophenones; D006801:Humans; D006816:Huntington Disease / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology; D007608:Kainic Acid / Q000627:therapeutic use; D007980:Levodopa / Q000627:therapeutic use; D008094:Lithium / Q000627:therapeutic use; D018377:Neurotransmitter Agents / Q000627:therapeutic use*; D010640:Phenothiazines; D013565:Sympatholytics / Q000627:therapeutic use*; D013747:Tetrabenazine / Q000627:therapeutic use; D005680:gamma-Aminobutyric Acid / Q000627:therapeutic use
D014150:Antipsychotic Agents; D002090:Butyrophenones; D018377:Neurotransmitter Agents; D010640:Phenothiazines; D013565:Sympatholytics; D007980:Levodopa; D005680:gamma-Aminobutyric Acid; D008094:Lithium; D000661:Amphetamine; D007608:Kainic Acid; D013747:Tetrabenazine
Recenti acquisizioni neurobiologiche e correlati farmaco-terapeutici nella corea di Huntington.